Talaris Therapeutics

+$0.27 (+3.80%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TALS and other ETFs, options, and stocks.

About TALS

Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT).

CEO
Scott Requadt
Employees
127
Headquarters
Louisville, Kentucky
Founded
2002

TALS Key Statistics

Market cap
305.53M
Price-Earnings ratio
—
Dividend yield
—
Average volume
56.35K
High today
$7.55
Low today
$7.04
Open price
$7.04
Volume
49.59K
52 Week high
$19.82
52 Week low
$5.70

TALS Earnings

-$1.30
-$0.87
-$0.43
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.45 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure